MECLIZINE HYDROCHLORIDE
- Product NDC
- 67296-2250
- Requested package NDC
- 67296-2250-3
- 11-digit product format
- 672962250
- Labeler code
- 67296
- Product ID
- 67296-2250_52ee8486-dfad-4e68-e063-6294a90a8476
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MECLIZINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Redpharm Drug
- Application
- ANDA202640
- Marketing category
- ANDA
- Marketing start
- 2023-09-14
- Substance
- MECLIZINE HYDROCHLORIDE
- Active strength
- 12.5 mg/1
- Pharmacologic classes
- Antiemetic [EPC]; Emesis Suppression [PE]
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202640-001 | MECLIZINE HYDROCHLORIDE | MECLIZINE HYDROCHLORIDE | 12.5MG | TABLET / ORAL | AA | 2012-09-17 | |
| A202640-002 | MECLIZINE HYDROCHLORIDE | MECLIZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AA | 2012-09-17 | |
| A202640-003 | MECLIZINE HYDROCHLORIDE | MECLIZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AA | 2012-09-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A202640-001 | AA |
| A202640-002 | AA |
| A202640-003 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202640-001 | MECLIZINE HYDROCHLORIDE | 12.5MG | TABLET / ORAL | AA | 2012-09-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202640-002 | MECLIZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AA | 2012-09-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202640-003 | MECLIZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AA | 2012-09-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202640-001 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202640-002 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202640-003 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MECLIZINE HYDROCHLORIDE | MECLIZINE | Bryant Ranch Prepack | dab43efd-bec6-472f-b13a-1c043914dcd1 | 2026-07-27 | Warnings, Adverse reactions | 202640 ANDA202640 |
| MECLIZINE HYDROCHLORIDE | MECLIZINE | Bryant Ranch Prepack | 1079db3f-d8ad-4c25-aa91-8ac8054ee4f2 | 2026-06-08 | Warnings, Adverse reactions | 202640 ANDA202640 |
| MECLIZINE HYDROCHLORIDE | MECLIZINE | Redpharm Drug | 52ee9258-8311-e6bd-e063-6294a90a567f | 2026-05-29 | Warnings, Adverse reactions | 202640 ANDA202640 67296-2250-3 67296-2250 67296225003 |
| MECLIZINE HYDROCHLORIDE | MECLIZINE | Redpharm Drug | 4727e7a9-eabb-a2a7-e063-6394a90a8754 | 2026-05-05 | Warnings, Adverse reactions | 202640 ANDA202640 |
| MECLIZINE HYDROCHLORIDE | MECLIZINE | A-S Medication Solutions | 55e262d9-d9dd-43a3-bc74-35e46dd391be | 2024-10-30 | Warnings, Adverse reactions | 202640 ANDA202640 |
| MECLIZINE HYDROCHLORIDE | MECLIZINE | A-S Medication Solutions | 949f7347-8c3a-43ce-b975-8d187096f09f | 2024-10-30 | Warnings, Adverse reactions | 202640 ANDA202640 |
| MECLIZINE HYDROCHLORIDE | MECLIZINE | NCS HealthCare of KY, LLC dba Vangard Labs | 1a33dec1-8d59-48bd-aaef-77d162194d57 | 2024-08-08 | Warnings, Adverse reactions | 202640 ANDA202640 |
| MECLIZINE HYDROCHLORIDE | MECLIZINE | Aurobindo Pharma Limited | beb3c7f2-c0f4-41d9-a903-63a6847e0997 | 2023-09-15 | Warnings, Adverse reactions | 202640 ANDA202640 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- MECLIZINE HYDROCHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MECLIZINE HYDROCHLORIDE | 12.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| HDP7W44CIO | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995624 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 52ee9258-8311-e6bd-e063-6294a90a567f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Status |
|---|---|---|---|---|---|---|
| 67296-2250-3 | 67296225003 | 30 TABLET in 1 BOTTLE (67296-2250-3) | 30 tablet | 2023-09-14 | 0 | Current |